TYPE II DIABETES MELLITUS
Clinical trials for TYPE II DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE II DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE II DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New diabetes drug safety check in pakistan: empagliflozin under Real-World watch
Disease control Recruiting nowThis study looks at how safe and effective empagliflozin (taken with or without metformin) is for adults with type 2 diabetes in Pakistan. About 156 people aged 18 to 65 with poorly controlled diabetes will be followed for 6 months. Researchers will track side effects like low bl…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE4 • Sponsor: Getz Pharma • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New weekly shot aims to tackle diabetes and obesity together
Disease control Recruiting nowThis study tests a new medicine called GL0034, given as a weekly shot, for people with type 2 diabetes who are also overweight or obese. About 285 adults will receive either the study drug or a placebo for up to 48 weeks. The main goal is to see if GL0034 can lower blood sugar le…
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Kabul community program aims to curb diabetes through group learning
Disease control Recruiting nowThis study tests a community-based program to help prevent and control type 2 diabetes in rural Kabul, Afghanistan. About 250 adults aged 20 and older will take part in group learning sessions. The goal is to see if the program is practical and well-liked by the community.
Matched conditions: TYPE II DIABETES MELLITUS
Phase: NA • Sponsor: HealthNet Transcultural Psychosocial Organization • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Kidney patients needed for diabetes drug dosing study
Knowledge-focused Recruiting nowThis study looks at how different levels of kidney function affect the way the body handles a new long-acting diabetes drug called GL0034. About 40 adults with type 2 diabetes will receive one dose of the drug. Researchers will measure drug levels in the blood and check for side …
Matched conditions: TYPE II DIABETES MELLITUS
Phase: PHASE1 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Knowledge-focused
Last updated May 01, 2026 23:43 UTC